COVID-19 trials registries data warehouse

 Return to trial list

Trial - NCT04633772


Column Value
Trial registration number NCT04633772
Full text link
Last imported at : Nov. 21, 2020, 12:31 a.m.
Source : ClinicalTrials.gov

First author
Last imported at : Nov. 11, 2021, 4:30 p.m.
Source : ClinicalTrials.gov

Robson AS Santos

Contact
Last imported at : Nov. 11, 2021, 4:30 p.m.
Source : ClinicalTrials.gov

santos@icb.ufmg.br

Registration date
Last imported at : Nov. 21, 2020, 12:31 a.m.
Source : ClinicalTrials.gov

2020-11-18

Recruitment status
Last imported at : Nov. 11, 2021, 4:30 p.m.
Source : ClinicalTrials.gov

Completed

Study design
Last imported at : Nov. 21, 2020, 12:31 a.m.
Source : ClinicalTrials.gov

RCT

Allocation
Last imported at : Nov. 21, 2020, 12:31 a.m.
Source : ClinicalTrials.gov

Randomized

Design
Last imported at : Nov. 21, 2020, 12:31 a.m.
Source : ClinicalTrials.gov

Parallel

Masking
Last imported at : Nov. 21, 2020, 12:31 a.m.
Source : ClinicalTrials.gov

Blind label

Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov

multi-center

Study aim
Last imported at : Nov. 21, 2020, 12:31 a.m.
Source : ClinicalTrials.gov

Treatment

Inclusion criteria
Last imported at : Nov. 21, 2020, 12:31 a.m.
Source : ClinicalTrials.gov

inclusion criteria: - admission to the intensive care unit with severe pneumonia criteria (clinical signs of pneumonia + one of the following criteria: respiratory rate greater than 30/minute; signs of respiratory effort, sato2 < 90% in room air); - covid-19 confirmed or highly suspicious (positive contact or suggestive image)

Exclusion criteria
Last imported at : Nov. 21, 2020, 12:31 a.m.
Source : ClinicalTrials.gov

- diagnosed with cancer (at any stage); - hemodynamic instability (need for vasopressors); - pregnant women; immunocompromised patients; - palliative care; - inclusion in any other interventionist study; - heart failure as a predominant cause of acute respiratory failure; - decompensated liver cirrhosis; - hiv +; - dialysis; - home / long-term oxygen therapy; - idiopathic pulmonary fibrosis

Number of arms
Last imported at : Nov. 21, 2020, 12:31 a.m.
Source : ClinicalTrials.gov

2

Funding
Last imported at : Nov. 21, 2020, 12:31 a.m.
Source : ClinicalTrials.gov

Erasme University Hospital

Inclusion age min
Last imported at : Nov. 21, 2020, 12:31 a.m.
Source : ClinicalTrials.gov

17

Inclusion age max
Last imported at : Nov. 21, 2020, 12:31 a.m.
Source : ClinicalTrials.gov

81

Countries
Last imported at : Nov. 21, 2020, 12:31 a.m.
Source : ClinicalTrials.gov

Brazil

Type of patients
Last imported at : Nov. 21, 2020, 12:31 a.m.
Source : ClinicalTrials.gov

Severe/critical disease at enrollment

Severity scale
Last imported at : Nov. 21, 2020, 12:31 a.m.
Source : ClinicalTrials.gov

7: Severe/critical disease at enrollment

Total sample size
Last imported at : Nov. 11, 2021, 4:30 p.m.
Source : ClinicalTrials.gov

112

primary outcome
Last imported at : Nov. 21, 2020, 12:31 a.m.
Source : ClinicalTrials.gov

supplemental oxygen-free days (SOFDs)

Notes
Last imported at : Nov. 21, 2020, 12:31 a.m.
Source : ClinicalTrials.gov

None

Phase
Last imported at : Feb. 25, 2021, 7:58 p.m.
Source : ClinicalTrials.gov

Phase 1/Phase 2

Arms
Last imported at : Nov. 21, 2020, 12:31 a.m.
Source : ClinicalTrials.gov

[{"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}, {"arm_notes": "", "treatment_id": 85, "treatment_name": "Angiotensin 1-7", "treatment_type": "Cardiovascular agents", "pharmacological_treatment": "Pharmacological treatment"}]